HIV-1 neuroimmunity in the era of antiretroviral therapy
- 4 January 2010
- journal article
- review article
- Published by Elsevier in Neurobiology of Disease
- Vol. 37 (3) , 542-548
- https://doi.org/10.1016/j.nbd.2009.12.015
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (P01 NS43985, P20RR15635, PO1 NS31492, R01NS034239, R37 NS36126)
This publication has 124 references indexed in Scilit:
- A Coat of Many Colors: Neuroimmune Crosstalk in Human Immunodeficiency Virus InfectionNeuron, 2009
- CD 4+ T cells in the pathobiology of neurodegenerative disordersJournal of Neuroimmunology, 2009
- Development of a platelet-activating factor antagonist for HIV-1 associated neurocognitive disordersJournal of Neuroimmunology, 2009
- Interleukin‐10‐secreting T cells define a suppressive subset within the HIV‐1‐specific T‐cell populationEuropean Journal of Immunology, 2009
- Acquired immunodeficiency syndrome and the blood-brain barrierJournal of NeuroVirology, 2009
- Lithium therapy for human immunodeficiency virus type 1–associated neurocognitive impairmentJournal of NeuroVirology, 2009
- HIV-1-Infected Astrocytes and the Microglial ProteomeJournal of Neuroimmune Pharmacology, 2008
- Validation of the CNS Penetration-Effectiveness Rank for Quantifying Antiretroviral Penetration Into the Central Nervous SystemArchives of Neurology, 2008
- Monocyte/macrophage trafficking in acquired immunodeficiency syndrome encephalitis: Lessons from human and nonhuman primate studiesJournal of NeuroVirology, 2008
- Proteolytic processing of SDF-1α reveals a change in receptor specificity mediating HIV-associated neurodegenerationProceedings of the National Academy of Sciences, 2006